Rigel Pharmaceuticals, Inc. earnings per share and revenue

RIGL earnings per share for the last quarter are 0.70 USD whereas the estimation was 0.06 USD which accounts for 1097.07% surprise. Company revenue for the same period amounts to 55.31 M USD despite the estimated figure of 41.94 M USD. Estimated earnings per share for the next quarter are 0.30 USD, and revenue is expected to reach 47.43 M USD. Also watch annual changes over time to get a bigger picture of RIGL earnings per share and revenue dynamics.